| 000 | 01678 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516043837.0 | ||
| 264 | 0 | _c20120131 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1440-1681 | ||
| 024 | 7 |
_a10.1111/j.1440-1681.2011.05560.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Yi | |
| 245 | 0 | 0 |
_aHeme oxygenase-1 could mediate the protective effects of hyperbaric oxygen preconditioning against hepatic ischemia-reperfusion injury in rats. _h[electronic resource] |
| 260 |
_bClinical and experimental pharmacology & physiology _cOct 2011 |
||
| 300 |
_a675-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHeme Oxygenase-1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperbaric Oxygenation _xmethods |
| 650 | 0 | 4 |
_aInterleukin-1beta _xblood |
| 650 | 0 | 4 |
_aIschemic Preconditioning _xmethods |
| 650 | 0 | 4 |
_aLiver Diseases _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aNecrosis _xprevention & control |
| 650 | 0 | 4 |
_aProtoporphyrins _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
| 650 | 0 | 4 |
_aTransaminases _xblood |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aSun, Xue-Jun | |
| 700 | 1 | _aLiu, Ji | |
| 700 | 1 | _aKang, Zhi-Min | |
| 700 | 1 | _aDeng, Xiao-Ming | |
| 773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 38 _gno. 10 _gp. 675-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1681.2011.05560.x _zAvailable from publisher's website |
| 999 |
_c20964829 _d20964829 |
||